Cochrane HIV/AIDS Group
Reviews, protocols and registered titles as of July, 2010 (Cochrane Library 2010:7)

Return to Cochrane HIV/AIDS Group main page

Suggestion: If you are trying to think of a suitable title to propose, look through this list of our existing reviews and reviews-in-progress. See if you can find a "gap" in what these reviews cover. That is to say, try to perceive an area of HIV/AIDS research that is not yet covered in a Cochrane review, but ought to be covered. This may be a useful way to think of a title in an area that interests you.

Please note: We are most interested in reviews addressing the urgent conditions of resource-constrained settings.

We are not accepting any proposals for reviews of diagnostic test accuracy at this time.

You can read the abstracts and plain language summaries of all Cochrane HIV/AIDS Group reviews, here.

Reviews of Behavioral, Social and Policy Prevention

  • REVIEW:  Abstinence-only programs for HIV infection prevention in high-income countries
  • REVIEW:  Abstinence-plus programs for HIV infection prevention in high-income countries
  • REVIEW:  Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men
  • REVIEW:  Harm reduction interventions to prevent HIV/AIDS transmission in involuntary detainees
  • REVIEW:  Home-based HIV voluntary counselling and testing (VCT) for improving uptake of HIV testing
  • REVIEW:  Interventions for improving the psychosocial well-being of children affected by HIV and AIDS.
  • REVIEW:  Mass media interventions for promoting HIV testing
  • REVIEW:  Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users
  • PROTOCOL:  Behavioral interventions for increasing the use of condoms in women with HIV
  • PROTOCOL: Behavioral interventions for reducing HIV infection in employees in occupational settings
  • PROTOCOL: Economic interventions for prevention of HIV risk and HIV infection
  • PROTOCOL: Interventions for HIV prevention in non-incarcerated criminal offenders
  • PROTOCOL: Interventions for reduction of stigma in people with HIV/AIDS
  • PROTOCOL: Interventions to modify sexual risk behaviours for preventing HIV in homeless youth
  • PROTOCOL:  Peer-based interventions for reducing morbidity and mortality in HIV-infected women
  • PROTOCOL: Rapid testing for improving uptake of HIV/AIDS services in people with HIV infection
  • PROTOCOL: School-based interventions to postpone sexual intercourse and promote condom use among adolescents
  • PROTOCOL: Structural and community-level interventions for increasing condom use to prevent HIV and other sexually transmitted infections
  • REGISTERED TITLE: Behavioral interventions to reduce the transmission of HIV infection among commercial sex workers and their clients in high-income countries
  • REGISTERED TITLE: Behavioral interventions to reduce the transmission of HIV infection among commercial sex workers and their clients in low-income and middle-income countries
  • REGISTERED TITLE: Community strengthening interventions for reducing mobidity and mortality in people living with HIV/AIDS in developing countries.
  • REGISTERED TITLE: Information and communication technologies (ICT) for promoting sexual and reproductive health (SRH) and preventing HIV infection in adolescents and young adults
  • REGISTERED TITLE: Interventions for increasing HIV testing and disclosure of HIV status in men who have sex with men (MSM)
  • REGISTERED TITLE: Sex venue-based interventions for preventing HIV infection in men who have sex with men (MSM)
  • REGISTERED TITLE: Social marketing interventions for preventing HIV infection in men who have sex with men (MSM)
  • REGISTERED TITLE: Targeted and/or interactive Internet-based interventions for preventing HIV infection in men who have sex with men (MSM)

Reviews of Biomedical Prevention

  • REVIEW:  Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure
  • REVIEW:  Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals
  • REVIEW:  Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection
  • REVIEW:  Condom effectiveness in reducing heterosexual HIV transmission
  • REVIEW:  Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1
  • REVIEW:  Interventions for preventing late postnatal mother-to-child transmission of HIV
  • REVIEW:  Male circumcision for prevention of heterosexual acquisition of HIV in men
  • REVIEW:  Nonoxynol-9 for preventing vaginal acquisition of HIV infection by women from men
  • REVIEW:  Population-based interventions for reducing sexually transmitted infections, including HIV infection
  • REVIEW:  Vaginal disinfection for preventing mother-to-child transmission of HIV infection
  • REVIEW:  Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection
  • PROTOCOL: Effectiveness and safety of HIV post-exposure prophylaxis after sexual, injecting-drug-use or other non-occupational exposure
  • PROTOCOL: Female condom for preventing HIV and sexually transmitted infections
  • PROTOCOL: Male circumcision for prevention of homosexual acquisition of HIV in men
  • PROTOCOL: Sperm washing to prevent HIV transmission from HIV-infected men but allowing conception in sero-discordant couples
  • REGISTERED TITLE: Antiretroviral interventions for preventing breastmilk transmission of HIV
  • REGISTERED TITLE: Vaccines for prevention of HIV infection

Reviews of Therapeutics, Prognostics and Diagnostics

  • REVIEW:  A combination drug of abacavir-lamivudine-zidovudine (Trizivir®) for treating HIV infection and AIDS
  • REVIEW:  Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection
  • REVIEW:  Adjunctive therapies for AIDS dementia complex
  • REVIEW:  Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV
  • REVIEW:  Antimotility agents for chronic diarrhoea in people with HIV/AIDS
  • REVIEW:  Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy
  • REVIEW:  Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women
  • REVIEW:  Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole
  • REVIEW:  Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV
  • REVIEW:  Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection
  • REVIEW:  Deworming helminth co-infected individuals for delaying HIV disease progression
  • REVIEW:  Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals
  • REVIEW:  Herbal medicines for treating HIV infection and AIDS
  • REVIEW:  Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults
  • REVIEW:  Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children
  • REVIEW:  Interventions for previously untreated patients with AIDS-associated Non-Hodgkin´s Lymphoma
  • REVIEW:  Interventions for squamous cell carcinoma of the conjunctiva in HIV-infected individuals
  • REVIEW:  Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children
  • REVIEW:  Interventions for treating AIDS-associated Hodgkin´s lymphoma in treatment-naive adults
  • REVIEW:  Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings)
  • REVIEW:  Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings
  • REVIEW:  Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults
  • REVIEW:  Prevention and treatment of cryptosporidiosis in immunocompromised patients
  • REVIEW:  Stavudine or zidovudine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals
  • REVIEW:  Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults.
  • REVIEW:  Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults
  • REVIEW:  Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults
  • REVIEW:  Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals
  • REVIEW:  Therapeutic drug monitoring of antiretrovirals for people with HIV
  • REVIEW:  Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection
  • REVIEW:  Treatment for anemia in people with AIDS
  • REVIEW:  Treatment for leiomyosarcoma and leiomyoma in children with HIV infection
  • REVIEW:  Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings
  • REVIEW:  Treatment of Kaposi's sarcoma in HIV-1 infected individuals with emphasis on resource poor settings
  • REVIEW:  Treatment of latent tuberculosis infection in HIV infected persons
    REVIEW:  Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults
  • PROTOCOL: Antidepressants for depression in adults with HIV infection
  • PROTOCOL: Antimicrobials for chronic AIDS-associated diarrhoea in Adults
  • PROTOCOL: Antiviral agents for treating CMV infection of the nervous system in people with HIV
  • PROTOCOL: Effect of preventive interventions for malaria on HIV-1 disease progression in non-pregnant adults
  • PROTOCOL: Effectiveness and safety of first-line fixed-dose TNF + EMC + EFZ for patients with HIV
  • PROTOCOL: Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age
  • PROTOCOL: Genotypic antiretroviral resistance testing at viral failure in people with HIV
  • PROTOCOL: Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection
  • PROTOCOL: Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection
  • PROTOCOL: Interventions for the prevention of mycobacterium avium complex in adults and children with HIV
  • PROTOCOL: Low dose versus high dose stavudine for treating people with HIV infection
  • PROTOCOL: Measles/MMR vaccine for infants born to HIV-positive mothers
  • PROTOCOL: Nucleic Acid Amplification Techniques (NATs) for early diagnosis of HIV-1 infections
  • PROTOCOL: Pneumococcal vaccine for prevention of Streptococcus pneumoniae infection in HIV infected individuals
  • PROTOCOL: PRO 140 (a CCR5 monoclonal antibody) for treatment in people with HIV infection
  • PROTOCOL: Ritonavir-boosted protease inhibitor-containing regimens versus non-boosted protease-inhibitor-containing regimens for reducing morbidity and mortality in people with HIV/AIDS
  • PROTOCOL: The effects of antiviral therapy of genital herpes in HIV-infected individuals
  • PROTOCOL: The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS
  • PROTOCOL: Topical treatments for HIV-related oral ulcers
  • PROTOCOL:  Treatment of active tuberculosis in patients with HIV infection
  • PROTOCOL: Treatment of drug-resistant tuberculosis in patients with HIV-1 infection
  • REGISTERED TITLE: Acupuncture and/or moxibustion for reducing morbidity and mortality in people with HIV infection
  • REGISTERED TITLE: Antifungal treatment for recurrent vulvovaginal candidiasis (thrush)
  • REGISTERED TITLE: Antifungal treatment for recurrent vulvovaginal candidiasis (thrush)
  • REGISTERED TITLE: Non-virologic tests for diagnosing virologic treatment failure in adults on highly active antiretroviral therapy for HIV infection
  • REGISTERED TITLE: Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis
  • REGISTERED TITLE: Statins for treatment of dyslipidemia in HIV-infected patients receiving highly active antiretroviral therapy
  • REGISTERED TITLE: Tenofovir or abacavir in three-drug combination therapy with three nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in adults
  • REGISTERED TITLE: Tenofovir or stavudine in three-drug combination therapy with two or three nucleoside reverse transcriptase inhibitors for initial treatment of HIV infection in adults

Reviews of Health Services and Care

  • REVIEW:  Aerobic exercise interventions for adults living with HIV/AIDS
  • REVIEW:  Anabolic steroids for the treatment of weight loss in HIV-infected individuals
  • REVIEW:  Family support for reducing morbidity and mortality in people with HIV/AIDS
  • REVIEW:  Home-based care for reducing morbidity and mortality in people infected with HIV/AIDS
  • REVIEW:  Interventions for educating traditional healers about STD and HIV medicine
  • REVIEW:  Iron supplementation for reducing morbidity and mortality in children with HIV
  • REVIEW:  Massage therapy for people with HIV/AIDS
  • REVIEW:  Micronutrient supplementation in children and adults with HIV infection

 

 

 

Copyright © 2010. The Regents of the University of California. All rights reserved.